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BAYESIAN INFERENCE AND MODEL CHOICE IN A HIDDEN
STOCHASTIC TWO-COMPARTMENT MODEL OF
HEMATOPOIETIC STEM CELL FATE DECISIONS1
By Youyi Fong, Peter Guttorp and Janis Abkowitz
University of Washington
Despite rapid advances in experimental cell biology, the in vivo
behavior of hematopoietic stem cells (HSC) cannot be directly ob-
served and measured. Previously we modeled feline hematopoiesis
using a two-compartment hidden Markov process that had birth
and emigration events in the first compartment. Here we perform
Bayesian statistical inference on models which contain two additional
events in the first compartment in order to determine if HSC fate
decisions are linked to cell division or occur independently. Pareto
Optimal Model Assessment approach is used to cross check the es-
timates from Bayesian inference. Our results show that HSC must
divide symmetrically (i.e., produce two HSC daughter cells) in order
to maintain hematopoiesis. We then demonstrate that the augmented
model that adds asymmetric division events provides a better fit to
the competitive transplantation data, and we thus provide evidence
that HSC fate determination in vivo occurs both in association with
cell division and at a separate point in time. Last we show that as-
suming each cat has a unique set of parameters leads to either a
significant decrease or a nonsignificant increase in model fit, suggest-
ing that the kinetic parameters for HSC are not unique attributes of
individual animals, but shared within a species.
1. The biology of hematopoiesis. Hematopoiesis is the process of blood
cell production. More precisely, it is the process in which hematopoietic stem
cells (HSCs) make fate decisions and through sequential divisions, differen-
tiate into progenitor cells. These cells in turn differentiate into white blood
cells, red blood cells or platelets. While a lot is known about how progenitor
cells differentiate, since their behavior has been studied both in vivo and
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in vitro, relatively little is known about HSC. This is due to the fact that
HSCs are difficult to isolate, as they do not have a completely unique phys-
ical or antigenic phenotype. In addition, in vivo, HSC decisions depend on
input from neighboring cells and cytokines and not just their intrinsic cell
programming. HSCs support the entire blood and immune system, and can
reconstitute hematopoiesis after transplantation. Understanding their kinet-
ics is of great importance. For example, this could lead to new treatments
for leukemia and more effective clinical HSC transplantation procedures.
An HSC basically has to fulfill two directives, to self-renew and to dif-
ferentiate. In addition, like all cells, an HSC eventually will die through
apoptosis. An HSC self-renews by dividing symmetrically into two identical
daughter cells, each of which becomes a new HSC. Since the normal func-
tion of an HSC requires input from cells and cytokines in its bone marrow
microenvironment, termed niche, a newly born HSC will die unless it finds a
niche in time. Biological data argue that there is a limited number of niches
available in an organism and this helps maintain the number of HSC in a
steady state in a normal adult [Abkowitz et al. (2002), Czechowicz et al.
(2007)]. The pool of progenitor cells is replenished by the differentiation of
HSC, which can happen in two ways conceptually. First, an HSC can be
cued to commit to a specific progenitor fate. Alternatively, an HSC can di-
vide into two cells, which are fated to become an HSC or a progenitor cell
respectively at or right after the time of division. We call this “asymmetric
division,” although from a mathematical perspective, one cannot distinguish
a fate decision programmed at mitosis from a fate decision resulting from
microenvironmental input at or immediately following cell division.
In Drosophila germ line cells, it is clear that the cell division event is
indeed asymmetric, that is, fate depends on the spindle orientation relative
to the Hub cell (niche) and results from the unequal distribution of intra-
cellular regulators and extracellular (Hub-derived) signals between daughter
cells during mitosis [reviewed in Knoblich (2008) and Yamashita and Fuller
(2008)]. In the mammalian system, this is less certain, although studies of
murine neuroprogenitors, muscle satellite cells and T cells (following con-
tact with an antigen presenting cell) suggest this occurs [Knoblich (2008)
and Chang et al. (2007)]. The elegant studies of Wu and colleagues [Wu
et al. (2007)] show that murine HSC/progenitor cells, defined as immature
by virtue of Notch transcription, divide asymmetrically in vitro. There is
no in vivo evidence to suggest that asymmetric divisions happen, however,
and importantly, observing asymmetric outcomes does not require that HSC
division and fate determination are mechanistically linked [see discussion in
Schroeder (2007)].
In order to get an idea of the contributions of the feline hematopoietic
stem cells to the progenitor cells, a specific set of experiments was designed
using female Safari cats. Safari cats are the offspring of matings between
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a domestic cat and the South American Geoffroy wild cat. Since these
two breeds of cat have had long separate developments, they express an
electrophoretically distinct phenotype of the X-chromosome-linked enzyme
glucose-6-phosphate dehydrogenase (G6PD). During embryogenesis, since
either the paternal or the maternal X-chromosome is inactivated, the fe-
male Safari cats have some somatic cells expressing the domestic-type G6PD
(d G6PD) and other expressing the Geoffroy-type G6PD (G G6PD). The
G6PD phenotype is retained after replication and differentiation, and it is
functionally neutral. That is, the cells that express it do not have significant
self-renewal or differentiation advantages. Therefore, it provides a binary
marker or label of each cell and its offspring. For more details on the exper-
iment, see Abkowitz et al. (1988, 1990, 1993).
Observing the percentage of progenitor cells expressing the d G6PD phe-
notype over a period of almost 6 years in normal female Safari cats (with
observations taken approximately every 4 weeks) did not seem to provide
much information about the HSC behavior. In fact, this percentage re-
mained relatively constant during the six years of observation, suggesting
that hematopoiesis is a polyclonal and stable process.
Since there might be more information in observing the hematopoiesis
process when it is supported by a much smaller number of stem cells, a
number of female Safari cats were irradiated in order to kill their bone
marrow (where HSCs reside in adults) and a small number of bone marrow
cells, collected prior to the radiation, were transplanted back. Since large
animals have relatively few HSCs compared to other cells in the marrow,
at the start of the experiment the transplanted cats are likely to contain
a very small number of HSCs. For this reason the process modeling the
HSC behavior should have a discrete state-space rather than a continuous
one. The behavior of the binary label (d G6PD versus G G6PD) within
the progenitor cells was then monitored in samples taken every two to six
weeks. Under this setting, the percentage of labeled cells is more variable
over time. For example, some cats showed wide clonal fluctuations during
the first year or so and then stabilized, suggesting that initial hematopoiesis
after the transplantation was supported by only one or two clones.
2. A stochastic model of hematopoiesis. We model the hematopoiesis as
a two-compartment model. The first compartment contains the HSC, while
the second contains the clones (i.e., the entire production) of committed
stem cells. In the first compartment we allow stochastic decisions to divide,
specialize or die, with fates depending on the type of event. Thus, an HSC
follows a birth (symmetric division with rate λ; when the maximum number
of niches is reached, one daughter cell dies immediately), death (apoptosis at
rate α) and emigration (through commitment with rate ν or through asym-
metric division with rate η). The second compartment gets input from com-
mitted stem cells, and the duration of productive life of a clone is modeled
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Table 1
A list of stochastic events. All events are modeled as Poisson events and the rate
parameters are listed in the last column
Name Short name Rate parameter
Symmetric division S λ
Commitment C ν
Clonal death D µ
Asymmetric division As η
Apoptosis Ap α
exponentially (clonal death with rate µ). Figure 1 is a schematic description
of the stochastic model. Table 1 lists all the stochastic events.
In this paper we will be studying several submodels of the one shown in
Figure 1 and a convention is adopted to name each model by concatenating
the short names of the stochastic events it contains. For example, a model
containing the symmetric division event, the commitment event and the
clonal death event is called a SCD model; add the asymmetric event and
the apoptosis event and we get the full model SCDAsAp.
It follows from the description of the experiment above that the total
number of cells both in compartments one and two in Figure 1 can be seen as
the sum of two independent and identically distributed population processes
that differ only in a label: d G6PD or G G6PD. In short, the population
process is two-dimensional in both compartments. One dimension is the
population of cells expressing the d phenotype, the other is the population
of cells expressing the G phenotype.
Denote the rate parameters collectively as ρ. Denote by ω the set of events
between time 0 and time T or, equivalently, the number of cells over time
in that time span. We call ω the path or state. Suppose ω is composed of
n events, which divide the time span [0, T ] into n+ 1 intervals denoted by
t0, . . . , tn. The probability density of ω given the rate parameters ρ is
f(ω|ρ) =
n−1∏
k=0
mk exp[−(zkλ+ zkν + zkα+ zkη+ xkµ)tk]
Fig. 1. A stochastic model of hematopoiesis.
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× exp[−(znλ+ znν + znα+ znη+ xnµ)tn],
where zk and xk are the numbers of cells/clones (either domestic or Ge-
offroy) in the first and second compartments, respectively, at the time of
the kth event (z0 and x0 are the numbers at time 0), mk = zkλ, zkν, zkα,
zkη or xkµ depending on whether the kth event is a symmetric division, a
commitment, an apoptosis, an asymmetric division event in the first com-
partment or a death event in the second compartment. Note that zk and xk
are not observed. We choose z0 and x0 to be 10 and 5, respectively (either
domestic or Geoffroy) via a combination of prior belief and sensitivity study
[Golinelli, Guttorp and Abkowitz (2006)].
In order to relate this model of the unobserved HSCs and their progenitors
to the actual observations, we assume that each clone contributes equally to
hematopoiesis, and sample certain types of cells (BFU-E plus CFU-GM). By
the assumption made, the number of d-labeled cells in the samples should
be binomially distributed with success probability reflecting the proportion
of d HSC in the second compartment. Specifically, denoting ti the time of
the ith observation, N(ti) the number of progenitor cells in the sample at
time ti, xd(ti) and xG(ti) the numbers of d-type and G-type clones in the
second compartment at time ti, the distribution of the number of d-type
cells Y (ti) is
[Y (ti)|ω]∼Binomial
(
N(ti),
xd(ti)
xd(ti) + xG(ti)
)
.
3. Some history. From a statistical point of view, parameter estimation
needs to involve the likelihood function. In the first set of papers in the
long-standing collaboration between Guttorp and Abkowitz [Abkowitz et al.
(1990), Guttorp, Newton and Abkowitz (1990)] we were able to perform a
complete likelihood analysis, with a nonstandard shape of the likelihood due
to the initial number of transplanted HSC being a parameter. There were
serious numerical difficulties in evaluating the likelihood, and a Markov chain
Monte Carlo approach to inference with varying state space was developed
to do a Bayesian analysis of the early cat transplant data [Newton, Guttorp
and Abkowitz (1992)].
When additional cat data proved this early model a poor fit, we devel-
oped the first version of the current model, which initially was analyzed
using simulation tools. Using some features of the observed data, we devel-
oped objective criteria to assess simulated paths. When a set of simulated
paths failed one or more of the criteria, those parameter values were deemed
infeasible. In essence, we were using the multiple decision tools of Pareto Op-
timization [Vincent and Grantham (1981)] and the Pareto Optimal Model
Assessment approach by Reynolds and Ford (1999) to determine possible
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parameter values, with an ad hoc approach to find “optimal” parameter
values.
A statistical approach, using estimating equations, was developed by
Catlin in her dissertation [Catlin (1997)] and applied to the cat data [Catlin,
Abkowitz and Guttorp (2001)], yielding parameter estimates with a tighter
range than those obtained from the Pareto optimization. Golinelli (2000)
studied a simplified version of the model and developed tools for calculating
the posterior distribution using Markov chain Monte Carlo methods. It was
computationally infeasible at the time to run sufficient numbers of MCMC
iterations for the convergence of the algorithm. With improved computing
facilities and a faster algorithm, Golinelli, Guttorp and Abkowitz (2006)
then calculated the posterior distributions for one of the first transplanted
cats, as well as that using all the cats. These distributions agree with and
thus confirm our previous simulation-based work, and are more precise than
the alternative method developed by Catlin, Abkowitz and Guttorp (2001).
In this paper we extend the Bayesian inference machinery developed in
Golinelli, Guttorp and Abkowitz (2006) for the SCD model to work with
other models. Basically we draw from the posterior distribution ρ,ω|Y by
using a Gibbs sampler that alternates between updates of ρ|ω,Y (parameter
update) and ω|ρ,Y (state update). The parameter update is rather easy
with the choice of gamma or uniform prior because we can write down the
conditional distribution of ρ|ω,Y analytically. The state update is achieved
by a Reversible Jump Metropolis–Hastings algorithm [Robert and Casella
(2004)]. Details are given in the Appendix.
The increased complexity in both the parameter space and the state space
requires that we run more MCMC iterations than before and the time to
run it is getting close to being prohibitive. In order to improve the perfor-
mance, we allow the state update for each cat to run in its own thread, thus
speeding up state updates, the more time-consuming part of the algorithm.
The program was run on a custom-built high-performance workstation. This
allows us to run more complicated models, as well as simultaneously ana-
lyze all the data from the transplanted cats. In particular, we are able to
fit various refined models (Sections 4 and 5) and assess the hypothesis that
all cats have the same parameter values (Section 6). We still use the Pareto
Optimal Model Assessment approach to rule out certain models (Section 4).
4. Essentialness of apoptosis, symmetric division and commitment events.
Based on scientific evidence we know that apoptosis does happen to all
somatic cells. Golinelli, Guttorp and Abkowitz (2006) chose to leave out
this event because simulation studies done in Abkowitz, Catlin and Gut-
torp (1996) indicated that apoptosis was not essential in reconstructing our
experimental observations and because of the computational challenge in
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Table 2
Integrated likelihoods of cats for various models. 100 weeks data. Gamma priors are
assumed
Models log pˆH(y) log pˆθ1(y) log pˆθ2(y) log pˆθ3(y) BF
SCD −682.15 −647.27 −649.24 −646.35 1.0
SCDAp −692.04 −659.28 −662.61 −660.09 0.00
CDAsAp −673.11 −645.84 −649.01 −647.41 1.2
SDAsAp −689.72 −668.17 −672.57 −676.71 0.00
SCDAs −670.34 −644.59 −644.30 −645.16 19
implementing it. With the recent progress in software and hardware, we at-
tempt reversible jump MCMC for the SCDAp model. The posterior means
for λ, ν,µ,α are 0.084, 0.00019, 0.038, 0.0024, separately. To find out whether
the SCDAp model provides a better fit to the data than the SCD model, we
estimate Bayes factors. To this end, we estimate the integrated likelihood
under each model with a stabilized harmonic mean estimator [Raftery et al.
(2007)]
pˆθ(y|M) =
(
1
B
B∑
i=1
1
pi(y|θi,M)
)−1
,
where θ is any subset of parameters in model M , θi is one draw from the
posterior distribution of θ, pi(y|θi,M) is the density of the data under model
M with all parameters other than θ integrated out, and B is the number of
draws used to calculate the harmonic mean. Depending on the choice of θ,
the estimator can have large or small variance. In our model, if we choose θ
to be the path, then the estimator has very large variance (data not shown).
But if we let θ be either λ, ν or µ, then pˆλ, pˆν and pˆµ all have much smaller
variance and are similar to each other (Table 2). The Bayes factor for com-
paring the SCDAp model and the SCDmodel, pˆθ(y|SCDAp)/pˆθ(y|SCD) = 0,
indicates that the SCD model is strongly preferred over the SCDAp model
for describing this data set. Since SCD is a submodel of SCDAp, this result
means that without the presence of the apoptosis event, the SCD model does
a good job of describing the data set. Adding the apoptosis event results in a
more complex model, which is penalized by the Bayes factor approach. This
result is consistent with Abkowitz, Catlin and Guttorp (1996) which shows
by the Pareto Optimal Model Assessment approach that the data contain
little information about the apoptosis rate.
Since asymmetric division can be viewed as combining symmetric division
and commitment in one step, questions arise as to whether it is possible
to leave out either symmetric division or commitment in the presence of
asymmetric division. To check the essentialness of symmetric division, we
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performed a Bayesian analysis of the CDAsAp model using a Gamma prior.
The Bayes factor comparing the CDAsAp model with the SCD model is 1.23
(Table 2). This Bayes factor is nonconclusive. We simulate 50 virtual cats
from the CDAsAp model using the means of the posterior distributions of
the rate parameters (ν = 0.00738, µ = 0.05969, η = 0.03338, α = 0.00426).
We then assess each virtual cat with the five assessment criteria developed
in Abkowitz, Catlin and Guttorp (1996). The distributions of each of the
first four criteria in the observed and in the virtual cats are compared using
Kolmogorov–Smirnov tests and P values are 0.00, 0.000, 0.000 and 0.000.
The die-out rate of the virtual cats is 100%. We also simulate virtual cats
from six randomly chosen sets of parameters from the posterior distributions.
While the first four tests produce variable P values, the die-out rates are all
higher than 96%. This strongly suggests that symmetric division is required
to explain the data, that is, the hematopoietic reserve (compartment 1)
cannot regenerate and cannot maintain continued hematopoiesis unless HSC
symmetrically divide.
Similarly, we did a Bayesian analysis of the SDAsAp model using a Gamma
prior. The Bayes factor comparing the SDAsAp model with the SCD model
is 0.00 (Table 2), suggesting that commitment is required to explain the data.
We simulate 50 virtual cats from the SDAsAp model using the means of
the posterior distributions of the rate parameters (λ= 0.0659, µ= 0.04538,
η = 0.00136, α= 0.00142). Comparison of the first four criteria between the
virtual cats and the observed cats results in the P values of 0.073, 0.005,
0.000 and 0.75. The die-out rate of the virtual cats is 0%. We also simulate
virtual cats from six randomly chosen sets of parameters from the poste-
rior distributions. The P values from testing the third criterion, the relative
amount of variation in the d-type progenitor percentage immediately fol-
lowing transplantation [Abkowitz, Catlin and Guttorp (1996)], are all 0.000.
This further supports the notion that commitment is essential to HSC kinet-
ics. The maintenance of hematopoiesis by a persisting cohort of progenitor
cells is not compatible with experimental observations.
5. Bayesian inference for SCDAs model. Table 3 reports the means and
95% HPD credible intervals of the posterior distributions of the parameters
for the SCDAs model. Those for the SCD model are reported as well for
comparison purpose. For the SCDAs model, the best estimates for λ, ν, µ
and η are 1 per 11 weeks, 1 per 13 weeks, 1 per 5.2 weeks, and 1 per 13 weeks,
respectively. The estimated symmetric division rates and commitment rates
are largely similar between the two models, while the clonal death rate in the
SCDAs model is a bit larger than that in the SCD model. This makes sense
because in the SCDAs model, in addition to commitment events, asymmetric
division events also contribute to the increase in the number of clones in the
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second compartment, thus requiring an increase in the death rate to maintain
a steady state.
The Pareto Optimal Model Assessment approach was previously used in
Abkowitz et al. (1988) to find the acceptable range of the parameters in
the SCDAp model. The same approach can also be used to validate the
parameter estimates obtained from Bayesian inference. Thus, we simulate
50 virtual cats using the means of the posterior distributions of parameters
for the SCDAs model. Figure 2 plots 20 paths. Comparison of the first four
criteria between the virtual cats and the observed cats results in the P
values of 0.074, 0.59, 0.34 and 0.41. The last criterion, the die-out rate, of
the simulated cats is 14%. While no die-outs were observed among the six
observed cats, this percentage is still less than 1/6.
In this Bayesian analysis, we have to specify priors for the parameters.
Although there is some information guiding the choice of priors, we want to
check the sensitivity of the posterior distributions on prior choice. To that
end, we run MCMC with two priors. Both priors assume that all param-
eters are independently and identically distributed. The “Gamma” priors
let each parameter be distributed as a Gamma distribution with shape pa-
rameter 5 and rate parameter 50. The “Uniform” prior lets each param-
eter be distributed as a uniform distribution between 0 and 0.5. While
the SCD model is fairly insensitive to the choice of priors [Golinelli, Gut-
torp and Abkowitz (2006)], the SCDAs model is quite sensitive, particu-
larly for clonal death rate and asymmetric division rate (Figure 3). For
these two rates, uniform priors lead to larger posterior means. Furthermore,
there appears to be little detailed information about asymmetric division
rate.
Both SCDAs and SCD are biologically reasonable models of hematopoiesis.
Do the data at hand provide any evidence of favoring one versus the other?
The Bayes factor comparing the SDAsAp model with the SCD model is
19 (Table 2), providing moderate evidence that SCDAs describes the data
better than SCD . Other than the Bayes factor approach, we could poten-
tially address this problem by a mixture model approach, treating the model
indicator I as a random variable and putting a Bernoulli(0.5) prior on it.
We try to construct a reversible jump MCMC to sample the posterior joint
Table 3
The means and 95% HPD credible intervals of the posterior distributions of parameters
for SCDAs and SCD models. Gamma prior and 100 weeks data
Symm division (λ) Commitment (ν) Clonal death (µ) Asym. division (η)
SCDAs 0.093 (0.044, 0.141) 0.079 (0.036, 0.125) 0.193 (0.118, 0.271) 0.078 (0.009, 0.159)
SCD 0.094 (0.052, 0.148) 0.079 (0.038, 0.137) 0.139 (0.081, 0.209)
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Fig. 2. Cats simulated from the mean of the posterior distributions of the SCDAs model.
Gamma priors are assumed.
Fig. 3. Posterior distributions of the parameters for both SCD and SCDAs models. Priors
and posteriors are drawn in dashed and solid lines, respectively. 100 weeks data. The prior
is Gamma(5,50) for the first row and Uniform(0,0.5) for the second row.
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distribution of I , parameters and path. Unfortunately, due to the large di-
mensionality of the path space, it seems very difficult to come up with a
proposal distribution for an RJMCMC algorithm that works.
6. Homogeneity of the cats. As we mentioned before, Golinelli, Guttorp
and Abkowitz (2006) showed that the posterior distributions of the rate pa-
rameters were fairly insensitive to the choice of priors when all six cats were
analyzed together. Golinelli, Guttorp and Abkowitz (2006) also showed that
when individual cats were analyzed separately, the posterior distributions
were quite sensitive to the choice of priors. This prompts us to test the
modeling assumption that the rate parameters are the same for all cats. In
order to test this assumption, we fit each cat separately with the SCDAs
model and the SCD model (Figure 4 left and right) using the Gamma prior
and compare the 95% posterior credible intervals of the rate parameters. It
appears that both λ and ν are quite similar across cats for both the SCDAs
model and the SCD model. In both models, µ shows a bigger variation, but
still all the credible intervals for individual cats overlap with the credible
interval for all cats together. η of the SCDAs model are also quite similar
across cats.
Fitting each cat separately is equivalent to fitting a model in which each
cat is allowed to have its own set of parameters (the heterogeneous model).
Viewed this way, we can use the Bayes factor approach to compare pairs
of models where each pair differs in how each cat’s parameters are treated.
The Bayes factor comparing the SCD model in which each cat is allowed
to have its own set of parameters and the SCD model in which all cats
have the same set of parameters is 19. For the SCDAs model, this compar-
ison yields a Bayes factor of 0.059. This tells us that in the smaller SCD
model, the heterogeneous model provides a better fit to the data, while
in the bigger model SCDAs, the heterogeneous model results in a worse
fit.
7. Discussion. In this paper we use a number of statistical inference
methods to answer some important questions related to hematopoiesis. It
is necessary for us to model hematopoiesis as a continuous time Markov
process because samples are collected from unevenly-spaced time intervals.
As a result, the sample space that our Gibbs sampler has to explore is very
large. We check the convergence by visual inspection of the trace plots and
by cusum plots [Yu (1995)].
Previously Golinelli, Guttorp and Abkowitz (2006) have shown that in the
SCD model the amount of information the data contain are different from
different rate parameters. More information is available for the symmetric
division rate and the commitment rate than for the clonal death rate. We
show here that in the SCDAs model, the same is true. Furthermore, the
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Fig. 4. 95% posterior credible intervals of the rate parameters for the SCDAs (left) and
SCD (right) model for individual cats. The circles in the middle of the intervals mark the
means of the posterior distributions. Dotted lines show the 95% posterior credible intervals
for when all six cats are analyzed together. The labels on the right of each panel are the
identifiers of the cats. Gamma prior, 100 weeks data.
amount of information for the asymmetric division rate is similar to that for
the clonal death rate. In other words, these two parameters are not estimated
very precisely.
The data we analyze in this paper are observations made up to 100 weeks
post-transplantation. Data from 100 weeks to 300 weeks post-transplantation
are also available. We choose to limit the analysis to 100 weeks data out
of consideration of the underlying physiological process. In the initial pe-
riod after transplantation, the number of HSC cells grow exponentially until
reaching the number of niches available. After that, following a symmetric
division event, one of the daughter cells may not have a niche available to
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it and end up dying [Schofield (1978)] or specializing (differentiating). We
call this the steady state. In the steady state, the number of HSC cells is
bounded by the number of niches available and the amount of information
for the rate parameters is limited. Since this mechanism operates even in
the SCD model, there is in effect a modest amount of asymmetric division
even in this case.
The model has been applied to other animals [Abkowitz et al. (2000),
Shepherd et al. (2007)] with results that indicate that the kinetics of
hematopoiesis varies substantially between animals. There are some sur-
prising invariants between species, such as an indication that the maximum
number of stem cells is similar for all animals, that the ratio of λ to ν
remains constant [Abkowitz et al. (2002)], and that there is no evidence
that the clone exhaustion parameter µ differs between species, although our
results indicate substantial uncertainty about this latter parameter. These
findings have been used to deduce parameter values for humans [Shepherd
et al. (2004), Catlin et al. (2009)].
There is independent evidence that the parameter values obtained in our
analyses are reasonable. Specifically, observations of telomere shortening in
granulocytes from cats with aging can be used to estimate the cumulative
numbers of HSC divisions at a point in time [Shepherd et al. (2007)]. While
the estimates in this paper are based on a stochastic model using only sym-
metric division, similar calculations indicate that even though the fitted
values for the SCDAs model will be about 185 divisions per lifetime, it is
quite consistent with the other animal models in the cited paper.
Recently there has been progress in studies of in vitro asymmetric fate de-
termination. Wu et al. (2007) for the first time demonstrated that hematopoi-
etic stem/progenitor cells undergo both symmetric and asymmetric divi-
sions. The study we have done in this paper is consistent with the occurrence
of asymmetric division in vivo and further provides an estimate of the rate
at which it happens.
APPENDIX
The state update is carried out using a Metropolis–Hastings–Green al-
gorithm which is a slight generalization and optimization of that reported
in Golinelli, Guttorp and Abkowitz (2006). In this appendix we only lay
out what is different and ask the readers to refer to Golinelli, Guttorp and
Abkowitz (2006) for more details. Denote by M the types of events in the
model we are interested in, by N the number of events in the current path,
and by [0, T ] the time span during which data are collected. Let (p1, p2, p3)
be a point from the probability simplex. The proposal probabilities for the
three moves defined in Golinelli, Guttorp and Abkowitz (2006) are as follows:
1. Deletion move: p1/N ;
14 Y. FONG, P. GUTTORP AND J. ABKOWITZ
2. Insertion move: p2/(2MT );
3. Shuffle move: p3/(NT ).
In calculating the acceptance probability
R=
p(ω′|θ)
p(ω|θ)
p(y|ω′)
p(y|ω)
q(ω|ω′)
q(ω′|ω)
|J |,
the Jacobian |J | is 1 for all models investigated in this paper since the dif-
feomorphisms are all identity relations. For speed and ease of computation,
we factor the log prior ratio log{p(ω′|θ)/p(ω|θ)} into three parts:
• The first part is log(
∏
k∈D
z′k−1
∏
k∈D x
′
k−1)− log(
∏
k∈D
zk−1
∏
k∈D xk−1),
where zk−1 denotes the number of cells in the first compartment right
before the kth event and xk−1 denotes the number of clones in the second
compartment right before the kth event. k ∈ D if and only if the kth event
is not a Death event.
• The second part is log(λS
′−SνC
′−CµD
′−DηF
′−FαA
′−A), where S, C, D, F
and A are the numbers of symmetric division, commitment, clonal death,
asymmetric division and apoptosis events, separately. When a model lacks
a certain event, simply drop the corresponding term. After simplification,
this part is just δ log ρ, where δ = 1, −1 or 0 for insertion, deletion and
shuffle moves, respectively, and ρ is the rate parameter corresponding to
the event being considered in the proposal.
• The third part is −(λ + ν + η + α)(S′z − Sz) − µ(S′x − Sx), where Sz
and Sx are the total time lived by the population in the first and second
compartment, respectively. Again, when a model lacks a certain event,
simply drop the corresponding term.
The likelihood ratio log{p(y|ω′)/p(y|ω)} is calculated similarly for all mod-
els. The proposal ratio log{q(ω|ω′)/q(ω′|ω)} is log(p1
p2
2MT
N+1
) for the insertion
move, log(p2
p1
N
2MT
) for the deletion move, and 0 for the shuffle move.
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